News Focus
News Focus
icon url

novicetrader

09/27/24 7:58 AM

#253243 RE: Mufaso #253242

Mufaso,thanks for pointing out the details on BIOA in your prior posts. Very much appreciated, your indepth analysis on the obesity stocks has always been very helpful.
icon url

DewDiligence

01/27/25 10:40 AM

#254408 RE: Mufaso #253242

VERU—(-48%)—reports purportedly-positive Enobosarm phase-2b data_for muscle-mass preservation by Wegovy users:

https://www.globenewswire.com/news-release/2025/01/27/3015441/11676/en/Veru-Announces-Positive-Topline-Data-from-Phase-2b-QUALITY-Clinical-Study-Enobosarm-Preserved-Lean-Mass-in-Patients-Receiving-WEGOVY-Semaglutide-for-Weight-Reduction.html

The safety database is still blinded, according to the PR.